KEAP1 and chronic kidney disease: Further studies have demonstrated that activation of IƙB/NF-ƙB and Keap1/Nrf2 signaling pathways could mediate or crosstalk these signaling pathways in both patients with CKD and experimental research studies (Chen et al., 2017a; Chen et al., 2017b; Chen et al., 2019c).